Search Results



Article Topics

Your search for Margaret von Mehren, MD matches 2 pages

Showing 1 - 2


sarcoma

Cautious Optimism About Olaratumab in Soft-Tissue Sarcoma

The current plethora of drugs in development for oncology is leading to the testing of novel agents in common as well as rare diseases. Targeted therapies have been a focus of great interest in soft-tissue sarcomas, with testing of a variety of oral tyrosine kinase inhibitors leading to the...

sarcoma

Eribulin in Liposarcoma: A Closer Look at the Comparative Data

Sarcoma therapy is a challenge for oncologists. Soft-tissue sarcomas encompass more than 50 different histologies, resulting in limited familiarity of management for many treating physicians. In addition, there have been few available effective therapies. The phase III trial of eribulin (Halavan) ...

Advertisement



Advertisement


Advertisement